4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-048166
Chief Scientific Officer sold 33,300 shares at an average $42.84 ($1,426,698)
- Chief Scientific Officer acquired 33,300 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-08-19 | Option exercise | +11,100 | $6.32 | $70,152 | 11,779 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-08-19 | Sale | −4,200 | $41.77 | $175,434 | 7,579 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-08-19 | Sale | −6,900 | $42.91 | $296,079 | 679 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-08-20 | Option exercise | +11,100 | $6.32 | $70,152 | 11,779 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-08-20 | Sale | −6,470 | $42.63 | $275,816 | 5,309 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-08-20 | Sale | −4,630 | $43.35 | $200,711 | 679 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-08-21 | Option exercise | +11,100 | $6.32 | $70,152 | 11,779 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-08-21 | Sale | −350 | $42.58 | $14,903 | 11,429 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-08-21 | Sale | −10,750 | $43.14 | $463,755 | 679 | D |
| Derivatives | |||||||
| ROBINS HARLAN S Chief Scientific Officer | 2020-08-19 | Option exercise · Stock Option (Right to Buy) | −11,100 | 355,800 | D | ||
| ROBINS HARLAN S Chief Scientific Officer | 2020-08-20 | Option exercise · Stock Option (Right to Buy) | −11,100 | 344,700 | D | ||
| ROBINS HARLAN S Chief Scientific Officer | 2020-08-21 | Option exercise · Stock Option (Right to Buy) | −11,100 | 333,600 | D | ||
| Open-market sales · 33,300 sh · avg $42.84 · $1,426,698 | |||||||
Loading xslF345X03/doc4.xml…